FYV6 Antibody

What is FYV6 and why is it important in splicing research?

FYV6 is a recently identified 2nd step splicing factor in yeast (Saccharomyces cerevisiae) with FAM192A as its human homolog. It plays a crucial role in the second catalytic step of pre-mRNA splicing, specifically in 3' splice site (SS) selection. FYV6 is particularly important for facilitating the usage of consensus, branch point (BP) distal 3' splice sites . Loss of FYV6 results in widespread activation of non-consensus, BP proximal 3' SS across the transcriptome, affecting approximately 20% of introns in yeast . The protein's importance lies in its ability to promote proper splice site selection, ensuring correct mRNA isoform production particularly under non-optimal growth conditions such as temperature stress .

How can I verify the specificity of a FYV6 antibody?

Verifying antibody specificity for FYV6 should involve multiple approaches:

• Western blot validation: Compare signals between wild-type and fyv6Δ strains. A specific antibody will show a band of the expected size (~19.7 kDa in yeast) in the wild-type that is absent in the knockout strain .

• Immunoprecipitation followed by mass spectrometry: This can confirm that the antibody pulls down FYV6 and its known interaction partners like Prp22 ATPase and components of the spliceosome .

• Recombinant protein controls: Express and purify recombinant FYV6 with appropriate tags and use this as a positive control alongside cellular extracts.

• Epitope mapping: Utilize the truncation mutants (such as Δ1-16, Δ1-23, Δ1-51, Δ134-173, and Δ103-173) that have been characterized to determine the specific region recognized by the antibody .

What are the key structural domains of FYV6 that antibodies might recognize?

Based on high-resolution structural analysis, FYV6 contains several distinct domains that antibodies might recognize:

The structure reveals that FYV6 contains three connected long α-helices that are critical for its function and position within the spliceosome . The N-terminal region (residues 17-23) forms a "hook" that interacts with the Prp22 RecA2 domain, while the C-terminal region interacts with Syf1 . Antibodies targeting these specific domains could be valuable for investigating distinct FYV6 functions.

How can I use FYV6 antibodies to investigate spliceosome dynamics?

To investigate spliceosome dynamics using FYV6 antibodies:

• Chromatin immunoprecipitation (ChIP): Use FYV6 antibodies to capture active spliceosomes on nascent transcripts, analyzing co-transcriptional splicing dynamics.

• Co-immunoprecipitation assays: Leverage the mutually exclusive binding of FYV6 and Yju2 to track spliceosome conformational changes. Since FYV6 binding is characteristic of the 2nd step conformation (C* and P complexes) while Yju2 is associated with 1st step conformations (B*, C complexes), antibodies against FYV6 can be used to specifically immunoprecipitate spliceosomes in the 2nd step .

• Immunofluorescence time course: Track the localization of FYV6 during splicing reactions, especially during temperature stress conditions when alternative splicing patterns change significantly .

• Proximity ligation assays: Use FYV6 antibodies in combination with antibodies against other spliceosome components (especially Prp22) to visualize their spatial relationships during different stages of splicing.

• Pulse-chase experiments: Combine with metabolic labeling to track the kinetics of FYV6 association with and dissociation from spliceosomes under various conditions.

What are the optimal fixation and extraction methods for detecting FYV6 in immunofluorescence studies?

For optimal immunofluorescence detection of FYV6:

How can I design a ChIP-seq experiment to study FYV6 association with specific pre-mRNAs?

A comprehensive ChIP-seq experimental design for FYV6:

• Cross-linking optimization:

  • Standard formaldehyde cross-linking (1%, 10 minutes) works for protein-DNA interactions

  • For protein-RNA interactions involving FYV6, use UV cross-linking (254 nm) or dual cross-linking with formaldehyde followed by a protein-specific cross-linker like DSP

• Chromatin preparation:

  • Sonicate to generate fragments of 200-300 bp for optimal resolution

  • Include RNase inhibitors throughout the protocol to preserve RNA integrity

  • For nascent RNA studies, consider using a nuclear isolation protocol before chromatin preparation

• Immunoprecipitation strategy:

  • Use pre-clearing with protein A/G beads to reduce background

  • Perform parallel IPs with anti-FYV6 antibodies and IgG controls

  • Include positive control IPs targeting known splicing factors (e.g., Prp22)

  • Consider sequential ChIP (Re-ChIP) with antibodies against Prp22 to enrich for functional complexes

• Library preparation and sequencing:

  • For standard ChIP-seq, prepare libraries using established protocols

  • For CLIP-seq variants, add steps for RNA isolation and library preparation

  • Sequence at high depth (>50 million reads) to capture transient interactions

• Data analysis considerations:

  • Map reads to both the genome and a database of splice junctions

  • Analyze enrichment at canonial vs. non-canonical 3' splice sites

  • Compare binding patterns in genes with short (<20 nt) vs. long (>20 nt) BP-to-3'SS distances

  • Integrate with RNA-seq data from wild-type and fyv6Δ strains to correlate binding with splicing outcomes

How can I use FYV6 antibodies to identify novel protein-protein interactions in the spliceosome?

To identify novel FYV6 protein-protein interactions:

• Proximity-dependent biotinylation (BioID or TurboID):

  • Generate fusion proteins of FYV6 with a biotin ligase

  • Perform proximity labeling experiments under different splicing conditions

  • Use streptavidin pulldown followed by mass spectrometry to identify proximal proteins

  • Compare results with known interaction partners like Prp22, Prp8, Slu7, and Syf1

• Cross-linking immunoprecipitation coupled with mass spectrometry (CLIP-MS):

  • Cross-link cells with formaldehyde or photo-reactive cross-linkers

  • Immunoprecipitate with anti-FYV6 antibodies

  • Analyze by mass spectrometry using protocols optimized for cross-linked peptides

  • Focus on identifying interactions that change under stress conditions, as FYV6 function is particularly important during temperature stress

• Co-immunoprecipitation with structural variants:

  • Use antibodies against FYV6 to perform co-IPs with extracts from cells expressing truncation mutants

  • Compare interaction profiles of wild-type FYV6 with those of the Δ1-16, Δ1-23, Δ1-51, Δ134-173, and Δ103-173 variants

  • Identify which domains are required for which interactions

• Yeast two-hybrid screening with domain-specific baits:

  • Use domains of FYV6 as baits in Y2H screens

  • Validate hits using co-IP with FYV6 antibodies

  • Focus on interactions that correlate with the functional domains identified in the cryo-EM structure

How does temperature stress affect FYV6 localization and function, and how can antibodies help investigate this?

Temperature stress significantly impacts FYV6 function, as evidenced by RNA-seq analysis showing more alternative 3' SS usage at 16°C than at optimal growth temperatures . To investigate this phenomenon:

• Immunofluorescence time-course experiments:

  • Track FYV6 localization before and after temperature shifts (30°C → 16°C or 30°C → 37°C)

  • Analyze changes in nuclear distribution patterns and co-localization with other splicing factors

  • Quantify changes in FYV6 signal intensity and distribution

• Chromatin association studies:

  • Perform ChIP or CLIP experiments at different temperatures

  • Compare FYV6 binding profiles across temperatures (16°C, 30°C, 37°C)

  • Focus on introns that show temperature-dependent alternative splicing

• Co-immunoprecipitation under different temperature conditions:

  • Perform FYV6 immunoprecipitation from cells cultured at different temperatures

  • Analyze changes in interaction partners through mass spectrometry or western blotting

  • Look for temperature-dependent modifications of FYV6 or its interacting proteins

• Pulse-chase experiments:

  • Use metabolic labeling to track newly synthesized FYV6

  • Follow its incorporation into spliceosomes at different temperatures

  • Combine with immunoprecipitation to isolate temperature-specific complexes

The RNA-seq data show that different sets of alternative 3' SS are activated at different temperatures in fyv6Δ strains, with few events detected under all three conditions (16°C, 30°C, 37°C) . This suggests temperature-specific roles for FYV6 that can be explored using antibody-based approaches.

What techniques can I use to study the competition between FYV6 and Yju2 for binding to the spliceosome?

The cryo-EM structure reveals that FYV6 and Yju2 binding to the spliceosome is mutually exclusive, with FYV6 characteristic of 2nd step conformations (C* and P complexes) and Yju2 associated with 1st step conformations (B*, C complexes) . To study this competition:

• Sequential immunoprecipitation:

  • First IP with anti-Yju2 antibodies to capture 1st step spliceosomes

  • Elute and perform a second IP with anti-FYV6 antibodies

  • Analyze the overlap (or lack thereof) between the two populations

• Single-molecule fluorescence resonance energy transfer (smFRET):

  • Label FYV6 and Yju2 with different fluorophores

  • Monitor the exchange between these factors during spliceosome assembly and catalysis

  • Measure FRET signals to determine proximity and binding kinetics

• Competitive binding assays in vitro:

  • Immobilize purified spliceosomes at specific assembly stages

  • Add fluorescently labeled FYV6 and Yju2 at varying concentrations

  • Monitor displacement patterns and binding affinities

• Chromatin immunoprecipitation (ChIP) time-course experiments:

  • Synchronize cells and perform ChIP with anti-FYV6 and anti-Yju2 antibodies

  • Analyze the temporal relationship between Yju2 and FYV6 occupancy

  • Focus on introns where FYV6 has a significant effect on 3' SS selection

• Proximity ligation assays:

  • Use pairs of antibodies (anti-FYV6/anti-spliceosome component and anti-Yju2/anti-spliceosome component)

  • Quantify signals to determine relative occupancy of each factor

  • Compare results between wild-type and mutant spliceosomes

Why might I observe non-specific bands when using FYV6 antibodies in western blots?

Non-specific bands in FYV6 western blots can occur for several reasons:

• Cross-reactivity with related proteins:

  • FYV6 shares structural features with other helical proteins in the spliceosome

  • Solution: Use extracts from fyv6Δ strains as negative controls to identify truly specific bands

  • Validate with recombinant FYV6 protein as a positive control

• Recognition of different FYV6 isoforms or modified forms:

  • FYV6 may undergo post-translational modifications affecting mobility

  • Solution: Perform immunoprecipitation followed by mass spectrometry to identify if bands represent modified FYV6

  • Compare band patterns in different subcellular fractions

• Degradation products:

  • FYV6 may be subject to proteolytic processing during sample preparation

  • Solution: Use fresh samples with multiple protease inhibitors

  • Compare different extraction methods (gentle vs. harsh lysis)

• Antibody batch variation:

  • Different antibody lots may have different specificity profiles

  • Solution: Validate each new lot against known positive and negative controls

  • Consider using monoclonal antibodies for consistent results

• Buffer and blocking conditions:

  • Inappropriate blocking or wash conditions can contribute to non-specific binding

  • Solution: Optimize blocking (5% BSA often works better than milk for nuclear proteins)

  • Increase salt concentration in wash buffers to reduce non-specific interactions

How can I distinguish between specific and non-specific FYV6 signals in immunofluorescence studies?

To distinguish specific from non-specific FYV6 signals:

• Genetic controls:

  • Include fyv6Δ strains as negative controls in all experiments

  • Use strains expressing tagged FYV6 (GFP-FYV6 or FYV6-FLAG) as positive controls

  • Compare antibody staining with the direct signal from tagged proteins

• Antibody validation controls:

  • Pre-absorb antibody with recombinant FYV6 protein before staining

  • Compare staining patterns between different antibodies targeting different FYV6 epitopes

  • Use secondary antibody-only controls to assess background

• Counterstaining strategy:

  • Co-stain with markers of known FYV6 interaction partners (e.g., Prp22)

  • Use nuclear markers to confirm the expected nuclear localization

  • Look for co-localization with spliceosome markers in nuclear speckles

• Signal quantification:

  • Measure signal-to-noise ratios in different cellular compartments

  • Compare intensity profiles across different experimental conditions

  • Use automated image analysis to reduce subjective interpretation

• Complementary techniques:

  • Validate localization patterns with biochemical fractionation followed by western blotting

  • Use super-resolution microscopy techniques to better distinguish specific signals

  • Confirm with live-cell imaging of fluorescently tagged FYV6

How can I optimize ChIP protocols for studying FYV6 interaction with pre-mRNAs containing different branch point to 3' splice site distances?

Optimizing ChIP protocols for studying FYV6-pre-mRNA interactions:

• Cross-linking optimization for RNA-protein interactions:

  • Test multiple cross-linking approaches: formaldehyde, UV (254 nm), or combinatorial approaches

  • Optimize cross-linking times separately for genes with short (<20 nt) vs. long (>20 nt) BP-to-3'SS distances

  • Consider using photoactivatable ribonucleoside-enhanced cross-linking for RNA-specific interactions

• Chromatin preparation strategies:

  • Use gentle sonication conditions to preserve RNA integrity

  • Include RNase inhibitors throughout the protocol

  • Consider native conditions (without cross-linking) for some experiments to detect stable interactions

• Immunoprecipitation conditions:

  • Compare different anti-FYV6 antibodies targeting different epitopes

  • Test various washing stringencies to preserve RNA-protein interactions

  • Include RNA spike-in controls to normalize between samples

• Controls and normalization:

  • Use ACT1-CUP1 reporters with various BP to 3' SS distances (9-50 nt) as internal controls

  • Include IgG controls and input samples for accurate normalization

  • Consider using calibrated spike-in chromatin from a different species

• Detection and analysis strategies:

  • For specific gene analysis, design primers spanning the BP-3'SS region

  • For genome-wide analysis, adapt CLIP-seq or RIP-seq protocols

  • In data analysis, group genes by BP-to-3'SS distance based on the finding that FYV6 is particularly important for splicing at distances ≥21 nt

How can FYV6 antibodies be used to investigate the role of this protein in disease models?

While FYV6 studies have primarily focused on yeast, its human homolog FAM192A may have roles in disease processes that can be investigated using antibodies:

• Cancer research applications:

  • Use anti-FAM192A antibodies to analyze expression in cancer vs. normal tissues

  • Investigate correlation between FAM192A levels and alternative splicing patterns in tumors

  • Study how FAM192A knockdown affects splicing of cancer-related genes

• Neurodegenerative disease models:

  • Investigate FAM192A roles in neuronal splicing regulation

  • Study potential changes in FAM192A localization or function in disease models

  • Examine how FAM192A impacts the splicing of disease-associated transcripts

• Developmental biology:

  • Track FAM192A expression and localization during embryonic development

  • Study the impact of FAM192A knockdown on developmental alternative splicing programs

  • Investigate tissue-specific roles in splicing regulation

• Comparative analysis in model organisms:

  • Use antibodies to compare FAM192A/FYV6 function across evolutionary diverse systems

  • Study conservation of the FYV6/FAM192A mechanism of 3' splice site selection

  • Investigate species-specific functions and interactions

What approach would you recommend for studying how post-translational modifications affect FYV6 function?

To study post-translational modifications (PTMs) of FYV6:

• Identification of PTMs:

  • Immunoprecipitate FYV6 using specific antibodies

  • Analyze by mass spectrometry to identify types and sites of modifications

  • Compare PTM profiles under different conditions (temperature stress, cell cycle stages)

• Functional analysis of PTMs:

  • Generate antibodies specific to modified forms of FYV6

  • Create point mutations at PTM sites and analyze effects on splicing patterns

  • Compare the interactions of modified and unmodified FYV6 with spliceosome components

• Dynamic regulation of PTMs:

  • Perform time-course experiments following splicing activation or stress induction

  • Use modification-specific antibodies to track changes in PTM levels

  • Correlate PTM changes with alterations in splicing efficiency or 3' SS selection

• Enzyme identification:

  • Use inhibitors or knockdowns of candidate enzymes (kinases, phosphatases, etc.)

  • Analyze effects on FYV6 modification state using modification-specific antibodies

  • Perform in vitro modification assays with purified enzymes and FYV6

• Structural impact assessment:

  • Use structural information from cryo-EM studies to predict how PTMs might affect FYV6 function

  • Focus on modifications near interaction surfaces with Prp22, Syf1, and other partners

  • Generate structural models incorporating PTMs to guide experimental design

How can I investigate the role of FYV6 in regulating alternative splicing under different stress conditions beyond temperature?

To study FYV6 roles in stress-responsive alternative splicing:

• Comprehensive stress panel analysis:

  • Expose cells to various stressors: oxidative stress, nutrient limitation, osmotic stress, etc.

  • Perform RNA-seq in WT and fyv6Δ backgrounds under each condition

  • Use FYV6 antibodies for ChIP-seq or RIP-seq under the same conditions

• Stress granule association studies:

  • Use immunofluorescence to assess FYV6 localization during stress

  • Determine if FYV6 associates with stress granules or other stress-induced structures

  • Analyze co-localization with markers of different cellular compartments

• Kinetic analysis of stress responses:

  • Perform time-course experiments following stress induction

  • Use FYV6 antibodies to track protein levels, localization, and interactions

  • Correlate changes in FYV6 with alterations in splicing patterns

• Integrated multi-omics approach:

  • Combine RNA-seq, ChIP-seq, and proteomics data across stress conditions

  • Use FYV6 antibodies for immunoprecipitation in all contexts

  • Develop computational models to predict FYV6-dependent splicing outcomes under different stresses

• Genetic interaction screens:

  • Test synthetic interactions between fyv6Δ and mutations in stress-response pathways

  • Use antibodies to verify protein expression and localization in double mutants

  • Focus on conditions where FYV6 shows the strongest phenotypes, such as cold stress